Summary
Market Segment as follows:
By Type
Existing Drugs
Akynzeo (Netupitant-Palonosetron FDC)
Aloxi (Palonosetron)
Emend (Aprepitant)
Kytril Generic (Granisetron)
Zofran Generic (Ondansetron)
Pipeline Drugs
SUSTOL (Granisetron Injection extended release)
Rolapitant
By Application
Serotonin Receptor Antagonists
NK1 Receptor Antagonists
By Company
Merck & Co., Inc.
GlaxoSmithKline plc
Tesaro, Inc.
Helsinn Group
F. Hoffmann-La Roche Ltd.
Heron Therapeutics, Inc.
Dr. Reddy's Laboratories Ltd.
Acacia Pharma
Sun Pharmaceutical Industry Ltd.
Otsuka Holdings Co., Ltd.
The main contents of the report including:
Section 1:
Product definition, type and application, global and China market overview;
Section 2:
Global and China Market competition by company;
Section 3:
Global and China sales revenue, volume and price by type;
Section 4:
Global and China sales revenue, volume and price by application;
Section 5:
China export and import;
Section 6:
Company information, business overview, sales data and product specifications;
Section 7:
Industry chain and raw materials;
Section 8:
SWOT and Porter's Five Forces;
Section 9:
Conclusion.
Interested in this report?
Get your sample now!
Table of Content
1 Market Overview
1.1 Market Segment Overview
1.1.1 Product Definition
1.1.2 Market by Type
1.1.2.1 Existing Drugs
1.1.2.2 Akynzeo (Netupitant-Palonosetron FDC)
1.1.2.3 Aloxi (Palonosetron)
1.1.2.4 Emend (Aprepitant)
1.1.2.5 Kytril Generic (Granisetron)
1.1.2.6 Zofran Generic (Ondansetron)
1.1.2.7 Pipeline Drugs
1.1.2.8 SUSTOL (Granisetron Injection extended release)
1.1.2.9 Rolapitant
1.1.3 Market by Application
1.1.3.1 Serotonin Receptor Antagonists
1.1.3.2 NK1 Receptor Antagonists
1.2 Global and China Market Size
1.2.1 Global Overview
1.2.2 China Overview
2 Global and China Market by Company
2.1 Global
2.1.1 Global Sales by Company
2.1.2 Global Price by Company
2.2 China
2.2.1 China Sales by Company
2.2.2 China Price by Company
3 Global and China Market by Type
3.1 Global
3.1.1 Global Sales by Type
3.1.2 Global Price by Type
3.2 China
3.2.1 China Sales by Type
3.2.2 China Price by Type
4 Global and China Market by Application
4.1 Global
4.1.1 Global Sales by Application
4.1.2 Global Price by Application
4.2 China
4.2.1 China Sales by Application
4.2.2 China Price by Application
5 China Trade
5.1 Export
5.2 Import
6 Key Manufacturers
6.1 Merck & Co., Inc.
6.1.1 Company Information
6.1.2 Product Specifications
6.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.2 GlaxoSmithKline plc
6.3 Tesaro, Inc.
6.4 Helsinn Group
6.5 F. Hoffmann-La Roche Ltd.
6.6 Heron Therapeutics, Inc.
6.7 Dr. Reddy's Laboratories Ltd.
6.8 Acacia Pharma
6.9 Sun Pharmaceutical Industry Ltd.
6.10 Otsuka Holdings Co., Ltd.
7 Industry Upstream
7.1 Industry Chain
7.2 Raw Materials
8 Market Environment
8.1 SWOT
8.2 Porter's Five Forces
9 Conclusion
Figure Existing Drugs Market Size and CAGR 2013-2018 (Million USD)
Figure Existing Drugs Market Size and CAGR 2013-2018 (Volume)
Figure Existing Drugs Market Forecast and CAGR 2019-2025 (Million USD)
Figure Existing Drugs Market Forecast and CAGR 2019-2025 (Volume)
Figure Akynzeo (Netupitant-Palonosetron FDC) Market Size and CAGR 2013-2018 (Million USD)
Figure Akynzeo (Netupitant-Palonosetron FDC) Market Size and CAGR 2013-2018 (Volume)
Figure Akynzeo (Netupitant-Palonosetron FDC) Market Forecast and CAGR 2019-2025 (Million USD)
Figure Akynzeo (Netupitant-Palonosetron FDC) Market Forecast and CAGR 2019-2025 (Volume)
Figure Aloxi (Palonosetron) Market Size and CAGR 2013-2018 (Million USD)
Figure Aloxi (Palonosetron) Market Size and CAGR 2013-2018 (Volume)
Figure Aloxi (Palonosetron) Market Forecast and CAGR 2019-2025 (Million USD)
Figure Aloxi (Palonosetron) Market Forecast and CAGR 2019-2025 (Volume)
Figure Emend (Aprepitant) Market Size and CAGR 2013-2018 (Million USD)
Figure Emend (Aprepitant) Market Size and CAGR 2013-2018 (Volume)
Figure Emend (Aprepitant) Market Forecast and CAGR 2019-2025 (Million USD)
Figure Emend (Aprepitant) Market Forecast and CAGR 2019-2025 (Volume)
Figure Kytril Generic (Granisetron) Market Size and CAGR 2013-2018 (Million USD)
Figure Kytril Generic (Granisetron) Market Size and CAGR 2013-2018 (Volume)
Figure Kytril Generic (Granisetron) Market Forecast and CAGR 2019-2025 (Million USD)
Figure Kytril Generic (Granisetron) Market Forecast and CAGR 2019-2025 (Volume)
Figure Zofran Generic (Ondansetron) Market Size and CAGR 2013-2018 (Million USD)
Figure Zofran Generic (Ondansetron) Market Size and CAGR 2013-2018 (Volume)
Figure Zofran Generic (Ondansetron) Market Forecast and CAGR 2019-2025 (Million USD)
Figure Zofran Generic (Ondansetron) Market Forecast and CAGR 2019-2025 (Volume)
Figure Pipeline Drugs Market Size and CAGR 2013-2018 (Million USD)
Figure Pipeline Drugs Market Size and CAGR 2013-2018 (Volume)
Figure Pipeline Drugs Market Forecast and CAGR 2019-2025 (Million USD)
Figure Pipeline Drugs Market Forecast and CAGR 2019-2025 (Volume)
Figure SUSTOL (Granisetron Injection extended release) Market Size and CAGR 2013-2018 (Million USD)
Figure SUSTOL (Granisetron Injection extended release) Market Size and CAGR 2013-2018 (Volume)
Figure SUSTOL (Granisetron Injection extended release) Market Forecast and CAGR 2019-2025 (Million USD)
Figure SUSTOL (Granisetron Injection extended release) Market Forecast and CAGR 2019-2025 (Volume)
Figure Rolapitant Market Size and CAGR 2013-2018 (Million USD)
Figure Rolapitant Market Size and CAGR 2013-2018 (Volume)
Figure Rolapitant Market Forecast and CAGR 2019-2025 (Million USD)
Figure Rolapitant Market Forecast and CAGR 2019-2025 (Volume)
Figure Serotonin Receptor Antagonists Market Size and CAGR 2013-2018 (Million USD)
Figure Serotonin Receptor Antagonists Market Size and CAGR 2013-2018 (Volume)
Figure Serotonin Receptor Antagonists Market Forecast and CAGR 2019-2025 (Million USD)
Figure Serotonin Receptor Antagonists Market Forecast and CAGR 2019-2025 (Volume)
Figure NK1 Receptor Antagonists Market Size and CAGR 2013-2018 (Million USD)
Figure NK1 Receptor Antagonists Market Size and CAGR 2013-2018 (Volume)
Figure NK1 Receptor Antagonists Market Forecast and CAGR 2019-2025 (Million USD)
Figure NK1 Receptor Antagonists Market Forecast and CAGR 2019-2025 (Volume)
Figure Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Size and CAGR 2013-2017 (Million USD)
Figure Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Size and CAGR 2013-2017 (Volume)
Figure Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Forecast and CAGR 2019-2025 (Million USD)
Figure Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Forecast and CAGR 2019-2025 (Volume)
Figure China Chemotherapy-Induced Nausea and Vomiting Drugs Market Size and CAGR 2013-2017 (Million USD)
Figure China Chemotherapy-Induced Nausea and Vomiting Drugs Market Size and CAGR 2013-2017 (Volume)
Figure China Chemotherapy-Induced Nausea and Vomiting Drugs Market Forecast and CAGR 2019-2025 (Million USD)
Figure China Chemotherapy-Induced Nausea and Vomiting Drugs Market Forecast and CAGR 2019-2025 (Volume)
Figure Global Market Sales Revenue Share by Company in 2017
Figure Global Market Sales Volume Share by Company in 2017
Figure China Market Sales Revenue Share by Company in 2017
Figure China Market Sales Volume Share by Company in 2017
Figure Global Market Sales Revenue Share by Type in 2017
Figure Global Market Sales Volume Share by Type in 2017
Figure China Market Sales Revenue Share by Type in 2017
Figure China Market Sales Volume Share by Type in 2017
Figure Global Market Sales Revenue Share by Application in 2017
Figure Global Market Sales Volume Share by Application in 2017
Figure China Market Sales Revenue Share by Application in 2017
Figure China Market Sales Volume Share by Application in 2017
Figure Industry Chain Overview
Figure Chemotherapy-Induced Nausea and Vomiting Drugs SWOT List
Figure Chemotherapy-Induced Nausea and Vomiting Drugs Porter's Five Forces
